Products4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
AIMOVIG
Product Details
NDC Product Code
55513-841Application Number
BLA761077Marketing Category
BLA (C73585)Route of Administration
SUBCUTANEOUSEffective Date
May 16, 2023ErenumabActive
Code: I5I8VB78VTClass: ACTIBQuantity: 70 mg in 1 mL
ACETATE IONInactive
Code: 569DQM74SCClass: IACTQuantity: 1.5 mg in 1 mL
SUCROSEInactive
Code: C151H8M554Class: IACTQuantity: 73 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.1 mg in 1 mL
AIMOVIG
Product Details
NDC Product Code
55513-843Application Number
BLA761077Marketing Category
BLA (C73585)Route of Administration
SUBCUTANEOUSEffective Date
May 16, 2023ErenumabActive
Code: I5I8VB78VTClass: ACTIBQuantity: 140 mg in 1 mL
SUCROSEInactive
Code: C151H8M554Class: IACTQuantity: 65 mg in 1 mL
ACETATE IONInactive
Code: 569DQM74SCClass: IACTQuantity: 2 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.1 mg in 1 mL
AIMOVIG
Product Details
NDC Product Code
55513-840Application Number
BLA761077Marketing Category
BLA (C73585)Route of Administration
SUBCUTANEOUSEffective Date
May 16, 2023SUCROSEInactive
Code: C151H8M554Class: IACTQuantity: 73 mg in 1 mL
ErenumabActive
Code: I5I8VB78VTClass: ACTIBQuantity: 70 mg in 1 mL
ACETATE IONInactive
Code: 569DQM74SCClass: IACTQuantity: 1.5 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.1 mg in 1 mL
AIMOVIG
Product Details
NDC Product Code
55513-842Application Number
BLA761077Marketing Category
BLA (C73585)Route of Administration
SUBCUTANEOUSEffective Date
May 16, 2023ErenumabActive
Code: I5I8VB78VTClass: ACTIBQuantity: 140 mg in 1 mL
ACETATE IONInactive
Code: 569DQM74SCClass: IACTQuantity: 2 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.1 mg in 1 mL
SUCROSEInactive
Code: C151H8M554Class: IACTQuantity: 65 mg in 1 mL